GlassScriptPhysician profile
Keith A Vasenius
NPI 1619998572
$6,213.99
in general payments reported to CMS, 2019-2025
48 companies · $302 in 2025
The $302 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $895 · 2020: $451 · 2021: $1,088 · 2022: $919 · 2023: $1,700 · 2024: $858 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,860.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,442.29 | 2021-2025 | Onyx Frontier, Symplicity G3, Abre |
| Novartis Pharmaceuticals Corporation | $675.03 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $502.59 | 2019-2023 | Xarelto |
| Pfizer INC. | $493.27 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $264.33 | 2019-2025 | Camzyos |
| Amarin Pharma, INC. | $253.03 | 2019-2022 | |
| Shockwave Medical, INC | $191.63 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $182.74 | 2021-2024 | Jot Dx, Gallant |
| Sanofi-Aventis U.S. LLC | $159.98 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $145.72 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $137.99 | 2023-2024 | Latitude Communicator Power Supply, Accolade Sr, Resonate El Icd Vr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.80 | 2019-2023 | Jardiance |
| Biotronik INC. | $123.15 | 2019-2024 | Nhancer Rx |
| Medtronic Vascular, INC. | $118.58 | 2019-2020 | |
| Amgen INC. | $115.93 | 2019-2024 | Repatha |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Vasenius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.